Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-11 of 11 for your search:
Drug:
sulindac
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized Chemoprevention Study of Eflornithine and Sulindac in Patients With a History of Adenomatous Polyps of the Colon
Phase:
Phase III
Type:
Prevention
Status:
Closed
Age:
40 to 80
Sponsor:
NCI
Protocol IDs:
UCIRVINE-UCI-2002-2261
, NCT00118365
2.
Phase II Clinical Trial of Sulindac, a Nonsteroidal Antiinflammatory Agent, for Chemoprevention of Colorectal Neoplasia (Summary Last Modified 05/1999)
Phase:
Phase II
Type:
Prevention
Status:
Closed
Age:
18 to 80
Sponsor:
NCI
Protocol IDs:
CPMC-IRB-1095-072
, NCI-P97-0110
3.
Phase IIB Randomized Study of Eflornithine (DFMO) and Sulindac in the Prevention of Colorectal Carcinoma in Patients With Previously Resected Colorectal Adenoma
Phase:
Phase II
Type:
Prevention
Status:
Closed
Age:
40 to 80
Sponsor:
NCI
Protocol IDs:
UCIRVINE-97-05
, NCI-P00-0150, NCT00005882
4.
Phase II Study of Sulindac and Docetaxel in Women With Metastatic or Recurrent Adenocarcinoma of the Breast
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
FCCC-01031
, FCCC-63723, NCI-G02-2080, NCT00039520
5.
Phase II Randomized, Placebo-Controlled Trial of Sulindac for Chemoprevention of Pre-malignant Colorectal Adenomas (Summary Last Modified 12/94)
Phase:
Phase II
Type:
Prevention
Status:
Closed
Age:
30 to 80
Sponsor:
Protocol IDs:
UUMC-9102
, NCI-P92-0018
6.
Phase II Randomized Study of Sulindac Versus Aspirin Versus Ursodiol for the Prevention of Colorectal Cancer in Patients With Aberrant Crypt Foci and a History of Colorectal Carcinoma or Adenoma
Phase:
Phase II
Type:
Prevention
Status:
Closed
Age:
40 to 80
Sponsor:
NCI
Protocol IDs:
MDA-ID-01454
, NCT00062023
7.
Phase II Randomized Chemoprevention Study of Atorvastatin Versus Oligofructose-Enriched Inulin (Raftilose Synergy 1) Versus Sulindac in Patients at Increased Risk of Developing Sporadic Colorectal Neoplasia
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Completed
Age:
40 and over
Sponsor:
NCI
Protocol IDs:
MAYO-030103
, MAY03-1-03, MAYO-1395-05, NCT00335504
8.
Phase I Study of Sulindac in Women at High Risk for Breast Cancer
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Closed
Age:
18 to 65
Sponsor:
NCI
Protocol IDs:
UARIZ-UAZ04-2-02
, UARIZ-HSC-0553, UAZ04-2-02, NCT00245024
9.
Randomized Study of Three Plant Phenolic Compounds Versus Sulindac (Part A) or Curcumin (Part B) in Prevention of Colon Cancer
Phase:
No phase specified
Type:
Prevention
Status:
Temporarily closed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
RUH-SSH-190-0600
, RUH-SSH-190-0698, NCI-V98-1425, NCT00003365
10.
Randomized Placebo-Controlled, Double-Blind Study in the Prevention of Colorectal Adenocarcinoma with Sulindac in Patients with Multiple Polyposis (Summary Last Modified 10/92)
Phase:
No phase specified
Type:
Prevention
Status:
Closed
Age:
18 and older
Sponsor:
NCI
Protocol IDs:
NCCTG-909251
, MAYO-909251, NCI-P91-0011
11.
Randomized Study of the Bioequivalency of Sulindac in Capsule Versus Tablet Formulations in Healthy Volunteers
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Completed
Age:
40 and over
Sponsor:
NCI
Protocol IDs:
MAYO-03-1-BIO
, MAYO-CPN0576, MAY03-1-BIO, MAYO-05-004233, NCT00343629
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute